Login / Signup
Complement control for COVID-19.
Markus Bosmann
Published in:
Science immunology (2021)
Excessive complement activation contributes to lung disease and adverse patient outcomes in COVID-19 (see the related Research Articles by Yan et al and Ma et al).
Keyphrases
</>
coronavirus disease
sars cov
respiratory syndrome coronavirus
weight gain
emergency department
drug induced